NCT01376154View on ClinicalTrials.gov

Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis)

CompletedOBSERVATIONAL

Enrollment

342

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

February 28, 2011

Conditions

Hepatitis B, Chronic

Interventions

DRUG

Lamivudine

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01376154 - Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis) | Biotech Hunter | Biotech Hunter